A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform by Riley Nolan | Jun 7, 2022A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools by Annie De Groot | Apr 13, 2020Better Epitope Discovery, De Groot et.al. 2020
